5560|10000|Public
5|$|While {{more studies}} of the {{long-term}} effects <b>of</b> <b>the</b> <b>drugs</b> are needed, specially for the newest treatments, existing data {{on the effects of}} interferons and glatiramer acetate indicate that early-initiated long-term therapy is safe and it is related to better outcomes.|$|E
5|$|A {{revised version}} of the game was resubmitted to the ACB and {{reclassified}} as MA 15+ on August 7, 2008, or not suitable for people {{under the age of}} 15 unless accompanied by a parent or adult guardian; this new rating ensured that the game could retail legally in Australia. According to the ACB board report, the drug content was not removed entirely from the {{revised version of}} the game, but the animation showing the actual usage <b>of</b> <b>the</b> <b>drugs</b> was removed; the minority view on the decision stated that the drug content was still enough to warrant a refused classification rating.|$|E
5|$|As time passes, Woodroof shows {{compassion}} towards gay, lesbian, and transgender {{members of}} the club and making money becomes less of a concern; his priority is provision <b>of</b> <b>the</b> <b>drugs.</b> Peptide T gets increasingly difficult to acquire, and in 1987 he files {{a lawsuit against the}} FDA. He seeks the legal right to take the protein, which has been confirmed as non-toxic but is still not approved. The judge is compassionate toward him and admonishes the FDA, but lacks the legal tools to do anything. As the film ends, on-screen text reveals that the FDA later allowed Woodroof to take peptide T for personal use and that he died of AIDS in 1992, seven years later than his doctors initially predicted.|$|E
50|$|Liquid {{preparations}} <b>of</b> <b>the</b> <b>drug</b> {{are also}} becoming increasing common; users then apply a solution <b>of</b> <b>the</b> <b>drug</b> to cigarettes {{and allow them}} to dry, resulting in a prepared dose <b>of</b> <b>the</b> <b>drug.</b>|$|R
50|$|Successful {{delivery}} <b>of</b> therapeutics to <b>the</b> {{intended target}} largely depends on <b>the</b> choice <b>of</b> <b>the</b> <b>drug</b> carrier. <b>The</b> criteria for an ideal drug carrier include maximum effect upon delivery <b>of</b> <b>the</b> <b>drug</b> to <b>the</b> target organ, evasion <b>of</b> <b>the</b> immune system <b>of</b> <b>the</b> body in <b>the</b> process <b>of</b> reaching <b>the</b> organ, retention <b>of</b> <b>the</b> therapeutic molecules from preparatory stages to <b>the</b> final delivery <b>of</b> <b>the</b> <b>drug,</b> and proper release <b>of</b> <b>the</b> <b>drug</b> for exertion <b>of</b> <b>the</b> intended therapeutic effect.|$|R
50|$|The {{three main}} {{categories}} <b>of</b> harm are <b>the</b> physical harm <b>of</b> <b>the</b> <b>drug</b> to <b>the</b> user, <b>the</b> <b>drug’s</b> tendency to cause dependence, and effects <b>of</b> <b>the</b> <b>drug</b> on society.|$|R
5|$|Churchill fully tooled-up—that is, installed, {{assembled}} and made ready for productive use—the Gatling Gun factory {{that opened in}} Birmingham in 1889. This was despite being an undischarged bankrupt. He had formed a partnership with his son, Charles Henry Churchill, and in 1888 he obtained another partner when John William Wright Gabriel disposed of his family's interest in a drugs manufacturer, Gabriel and Troke, and joined the Churchills. This partnership may explain how {{he was able to}} complete the work in Birmingham despite his financial status. Despite the assertion by biographer David Jeremy that J W W Gabriel disposed <b>of</b> <b>the</b> <b>drugs</b> manufacturing interest, a notice in The London Gazette for 1885 shows his father, John Wild Gabriel, ending a partnership with Troke, and that Troke then formed a similar arrangement with another person.|$|E
5|$|He {{writes that}} these {{positive}} results are achieved {{in a number}} of ways. Sometimes the industry-sponsored studies are flawed by design (for example by comparing the new drug to an existing drug at an inadequate dose), and sometimes patients are selected to make a positive result more likely. In addition, the data is analysed as the trial progresses. If the trial seems to be producing negative data it is stopped prematurely and the results are not published, or if it is producing positive data it may be stopped early so that longer-term effects are not examined. He writes that this publication bias, where negative results remain unpublished, is endemic within medicine and academia. As a consequence, he argues, doctors may have no idea what the effects are <b>of</b> <b>the</b> <b>drugs</b> they prescribe.|$|E
5|$|In modern medicine, {{around a}} quarter <b>of</b> <b>the</b> <b>drugs</b> {{prescribed}} to patients {{are derived from}} medicinal plants, and they are rigorously tested. In other systems of medicine, medicinal plants may constitute the majority of what are often informal attempted treatments, not tested scientifically. Medicinal plant use ranges from the mainstream, where some <b>of</b> <b>the</b> <b>drugs</b> used are derived from plants, to traditional medicine where plants form {{the bulk of the}} substances administered. The World Health Organization estimates, without reliable data, that some 80 percent of the world's population depends mainly on traditional medicine (including but not limited to plants); perhaps some two billion people are largely reliant on medicinal plants. The use of plant-based materials including herbal remedies and so-called nutraceuticals, foods with supposed health benefits, is increasing quickly in developed countries. This brings attendant risks of toxicity and other effects on human health, despite the safe image of herbal remedies. Herbal medicines have been in use since long before modern medicine existed; there was and often still is little or no knowledge of the pharmacological basis of their actions, if any, or of their safety. The World Health Organization formulated a policy on traditional medicine in 1991, and since then has published guidelines for them, with a series of monographs on widely used herbal medicines.|$|E
50|$|But <b>the</b> value <b>of</b> KD is also {{affected}} by the conformation, bonding and size <b>of</b> <b>the</b> <b>drug</b> and <b>the</b> receptor. The higher the KD the lower <b>the</b> affinity <b>of</b> <b>the</b> <b>drug.</b>|$|R
40|$|<b>The</b> {{development}} <b>of</b> <b>the</b> novel therapeutic agents {{or drugs}} will be widely affected by Parameters {{related to the}} chemistry (structure activity relationship), Pharmacology (mechanism <b>of</b> action <b>of</b> <b>the</b> <b>drug)</b> and <b>the</b> Pharmacokinetic profile <b>of</b> <b>the</b> <b>drug</b> (metabolism characteristics) will play an important role. Before a drug is newly launched in the market various pre clinical studies has to be undertaken to determine the efficacy, toxicological and <b>the</b> pharmacokinetic profile <b>of</b> <b>the</b> <b>drug.</b> In <b>the</b> clinical studies where <b>the</b> <b>drugs</b> has to be tested on the living beings, much concentration {{has been done on}} <b>the</b> safety profile <b>of</b> <b>the</b> <b>drug</b> which is <b>the</b> only defined factor for its approval and use in the market...|$|R
50|$|<b>The</b> label <b>of</b> <b>the</b> <b>drug</b> {{states that}} it is a {{compounded}} drug, as well as <b>the</b> name <b>of</b> <b>the</b> outsourcing facility, the lot or batch number <b>of</b> <b>the</b> <b>drug,</b> dosage form and strength, and other key information.|$|R
5|$|Lilly's {{greatest}} {{contributions to}} the industry were his standardized and methodical production of drugs, his dedication to research and development, and the therapeutic value <b>of</b> <b>the</b> <b>drugs</b> he created. As {{a pioneer in the}} modern pharmaceutical industry, many of his innovations later became standard practice. Lilly's ethical reforms, in a trade that was marked by outlandish claims of miracle medicines, began a period of rapid advancement in the development of medicinal drugs. During his lifetime, Lilly had advocated for federal regulation on medicines; his son, Josiah, continued that advocacy following his father's death.|$|E
5|$|Microbial {{communities}} {{produce a}} vast array of biologically active chemicals that are used in competition and communication. Many <b>of</b> <b>the</b> <b>drugs</b> in use today were originally uncovered in microbes; recent progress in mining the rich genetic resource of non-culturable microbes has led to the discovery of new genes, enzymes, and natural products. The application of metagenomics has allowed the development of commodity and fine chemicals, agrochemicals and pharmaceuticals where the benefit of enzyme-catalyzed chiral synthesis is increasingly recognized.|$|E
5|$|The Federation {{starship}} Enterprise, {{under the}} command of Captain Jean-Luc Picard (Patrick Stewart), brings aboard the elderly Admiral Mark Jameson and his wife Anne (Marsha Hunt) on request of Karnas (Michael Pataki), the Governor of Mordan IV. Karnas warns that a dissident terrorist group has taken a Federation Ambassador and his staff hostage, and demand to speak to a negotiator. Jameson had negotiated a previous settlement on Mordan IV. As the ship travels to Mordan IV, they find that Jameson is becoming stronger and more able to move about on his own, and is no longer showing signs of the terminal Iverson's Disease he was known to have before he was beamed aboard. The crew discovers that Jameson has been taking an array of drugs to reverse the aging process over the last two years, and only recently has taken an overdose <b>of</b> <b>the</b> <b>drugs</b> to prepare himself for the negotiations. Jameson begins to appear younger and full of energy, but has frequent pains {{as a result of the}} overdose. By the time they are nearing Mordan, Jameson now appears as a young adult.|$|E
50|$|Heart {{doctors at}} the Cleveland Clinic then voted {{unanimously}} not to permit <b>the</b> prescription <b>of</b> <b>the</b> <b>drug</b> to its patients. Following this, the United States Department of Justice announced an inquiry into <b>the</b> marketing <b>of</b> <b>the</b> <b>drug.</b>|$|R
5000|$|In October 2014, NICE {{announced}} that NHS England would not fund use <b>of</b> <b>the</b> <b>drug,</b> due to data uncertainties in Roche's application. [...] In June 2015, NICE {{announced that}} it would fund restricted use <b>of</b> <b>the</b> <b>drug.</b>|$|R
50|$|Only <b>the</b> unbound {{fraction}} <b>of</b> <b>the</b> <b>drug</b> undergoes metabolism in {{the liver}} and other tissues. As <b>the</b> <b>drug</b> dissociates from <b>the</b> protein more and more drug undergoes metabolism. Changes in <b>the</b> levels <b>of</b> free <b>drug</b> change <b>the</b> volume <b>of</b> distribution because free drug may distribute into the tissues leading to a decrease in plasma concentration profile. For <b>the</b> <b>drugs</b> which rapidly undergo metabolism, clearance is dependent on the hepatic blood flow. For drugs which slowly undergo metabolism, changes in <b>the</b> unbound fraction <b>of</b> <b>the</b> <b>drug</b> directly change <b>the</b> clearance <b>of</b> <b>the</b> <b>drug.</b>|$|R
5|$|The {{protective}} effect {{does not begin}} immediately, and people visiting areas where malaria exists usually start taking the drugs one to two weeks before arriving and continue taking them for four weeks after leaving (except for atovaquone/proguanil, which only needs to be started two days before and continued for seven days afterward). The use of preventative drugs is often not practical for {{those who live in}} areas where malaria exists, and their use is usually only in pregnant women and short-term visitors. This is due to the cost <b>of</b> <b>the</b> <b>drugs,</b> side effects from long-term use, and the difficulty in obtaining anti-malarial drugs outside of wealthy nations. During pregnancy, medication to prevent malaria has been found to improve the weight of the baby at birth and decrease the risk of anemia in the mother. The use of preventative drugs where malaria-bearing mosquitoes are present may encourage the development of partial resistance.|$|E
5|$|The use of bone {{building}} drugs, like bisphosphonates and anti-RANKL drugs {{require special}} consideration with implants, {{because they have}} been associated with a disorder called Bisphosphonate-associated osteonecrosis of the jaw (BRONJ). The drugs change bone turnover, which is thought to put people at risk for death of bone when having minor oral surgery. At routine doses (for example, those used to treat routine osteoporosis) the effects <b>of</b> <b>the</b> <b>drugs</b> linger for months or years but the risk appears to be very low. Because of this duality, uncertainty exists in the dental community about how to best manage the risk of BRONJ when placing implants. A 2009 position paper by the American Association of Oral and Maxillofacial Surgeons, discussed that the risk of BRONJ from low dose oral therapy (or slow release injectable) as between 0.01 and 0.06 percent for any procedure done on the jaws (implant, extraction, etc.). The risk is higher with intravenous therapy, procedures on the lower jaw, people with other medical issues, those on steroids, those on more potent bisphosphonates and people who have taken the drug for more than three years. The position paper recommends against placing implants in people who are taking high dose or high frequency intravenous therapy for cancer care. Otherwise, implants can generally be placed and the use of bisphosphonates does not appear to affect implant survival.|$|E
5|$|After his dad dies {{along with}} his wife, he nearly dies himself of {{overdose}} for guilt, since he told Cameron they're leaving, as he kills them. After he finds out who raped John Paul several months ago, {{the two of them}} have a fight and he drunkenly sleeps with Sinead. He's supportive to John Paul about his trial but he keeps taking drugs. After he discovers Tegan has a cancer, he gets high yet again in front of Amy and the kids. He then has a one-night stand with a man, he doesn't remember. By his and Lockie's fault, John Paul is sent to hospital because <b>of</b> <b>the</b> <b>drugs.</b> He decides to go to rehab. After that, he faces his abusive stepfather Terry and later proposes to John Paul, who accepts. They have a Christmas wedding, that is ruined when Sinead says she's expecting Ste's child. John Paul eventually forgives Ste and agrees to look after their baby with them. Ste then gets the devastating news that he's HIV positive, but John Paul sticks by his side. He is bothered with his friendship with Sinead and thinks they could be romantically involved, which Ste denies. Sinead falls in love with Ste and she wants to separate Ste and John Paul. She finds out John Paul kissed his student, Harry, Tony's son, unknowingly after one of their fights, and tries to frame him but Ste gets attacted in a hate crime. John Paul and Ste later split up and Sinead gives birth to their daughter, Hannah. Ste lives with them but is shocked when he overhears that Sinead loves him. After her heated words, he uses drugs again, but later pleads Sinead to not leave him and give them a chance as a couple, which confuses everyone. Ste than starts seeing Harry, even though he doesn't want to hurt Sinead. When she discovers, she leaves along with Hannah, which devastates Ste. He starts to date Harry behind Tony's back, but he is eventually found out. They later start dating for real but Ste breaks up with him as he thinks he's too young to be with someone like him. They later get back together but after Harry thinks he broke his promise not to take drugs and wants to end it with him, Ste accepts John Paul's offer to meet up and try again, but then when he sees Harry, John Paul understands he doesn't want him and Ste will end up with Harry. They live with Ste's sisters but Cameron, the man Leela had Peri with, doesn't want him with them and with false accusations, they both leave and become homeless. Later, when Ste is determinated to deal drugs again, Harry sleeps with another man for money. When Ste finds out the truth, they break up and Cameron gives him crystal meth. Ste becomes addicted and even when he and Harry get back together, he can't stop. When Harry finds out, he and Tony try to help him and get him into rehab.|$|E
30|$|Equation 6 {{showed that}} {{increasing}} the homogenization time would significantly (p[*]<[*] 0.05) decrease <b>the</b> %EE <b>of</b> <b>the</b> <b>drug.</b> Longer homogenization time could strip or peel off <b>the</b> <b>drug</b> molecules attached at <b>the</b> outer surface <b>of</b> <b>the</b> nanoparticles, {{which resulted in}} a lower %EE <b>of</b> <b>the</b> <b>drug</b> in <b>the</b> HVD-NLCs. In contrast, increasing the surfactant concentration resulted in a higher %EE <b>of</b> <b>the</b> <b>drug</b> in <b>the</b> HVD-NLCs. This could be due to higher surfactant concentration would increase its outer surface coating of NLCs, where part <b>of</b> <b>the</b> <b>drug</b> would be entrapped in it. Zhuang et al. and Das et al. suggested that an adequate concentration of surfactant is essential for <b>the</b> solubilization <b>of</b> <b>drug</b> molecules inside <b>the</b> lipid lattice and at <b>the</b> outer surface <b>of</b> nanoparticles [9, 10].|$|R
40|$|Pharmacokinetics {{studies were}} {{performed}} in healthy red Sokoto goats using chloramphenicol 25 mg kg - 1. Following <b>the</b> <b>drug</b> administration intravenously and intramuscularly samples of plasma were {{obtained in the}} goats at various time intervals. Measurable blood levels <b>of</b> <b>the</b> <b>drug</b> were obtained in goats for 6 h after intravenous injection and for 9 h after intramuscular administration. A mean plasma concentration of chloramphenicol (25. 63 � 2. 01 μg mL - 1) was obtained at 0. 08 h (5 min) after <b>the</b> intravenous administration <b>of</b> <b>the</b> <b>drug</b> while <b>the</b> peak plasma concentration <b>of</b> <b>the</b> <b>drug</b> following intramuscular treatment was 9. 64 � 0. 74 �g mL - 1 after 0. 25 h (30 min). <b>The</b> apparent volume <b>of</b> distribution and <b>the</b> total body clearance <b>of</b> chloramphenicol from <b>the</b> Sokoto red goats �were �higher after intramuscular than intravenous administration. About 80 % <b>of</b> <b>the</b> <b>drug</b> administered intramuscularly reached the plasma. This result has yielded baseline data for further investigation(s) <b>of</b> <b>the</b> <b>drug...</b>|$|R
30|$|<b>The</b> {{accuracy}} <b>of</b> <b>the</b> {{method was}} ascertained by recovery method. When the method {{was used for}} extraction and subsequent analysis <b>of</b> <b>the</b> <b>drug</b> in <b>the</b> dosage form after spiking with 50 %, 100 %, and 150 % <b>of</b> <b>the</b> <b>drug,</b> <b>the</b> recovery was 100.05 % (99.7 % to 100.9 %).|$|R
25|$|Corby {{stated that}} she had no {{knowledge}} <b>of</b> <b>the</b> <b>drugs</b> until the bodyboard bag was opened by customs officers.|$|E
25|$|In 2011, after {{pressure}} by activist organizations, {{the manufacturers of}} sodium thiopental and pentobarbital halted supply <b>of</b> <b>the</b> <b>drugs</b> to U.S. prisons performing lethal injections and required all resellers to do the same.|$|E
25|$|The most {{important}} measure is prevention – avoidance <b>of</b> <b>the</b> <b>drugs</b> and foods that cause hemolysis. Vaccination against some common pathogens (e.g. hepatitis A and hepatitis B) may prevent infection-induced attacks.|$|E
40|$|<b>The</b> success <b>of</b> local <b>drug</b> {{delivery}} and activation depends on several factors: • <b>the</b> degree <b>of</b> systemic distribution • localization <b>of</b> <b>the</b> <b>drug</b> delivery • permeation <b>of</b> <b>the</b> <b>drug</b> into <b>the</b> target tissue • timing <b>of</b> <b>the</b> local <b>drug</b> delivery or activation. C. T. W. Moonen 1 MR temperature mapping in local drug {{delivery and}} thermotherapy...|$|R
40|$|AbstractA {{conjugate}} <b>of</b> <b>the</b> antineoplastic <b>drug</b> doxorubicin (DXR) with maleylated {{bovine serum}} albumin (MBSA) {{was taken up}} by a human histiocytic lymphoma cell line (U 937) through the high efficiency process of scavenger receptor-mediated endocytosis resulting in a sixfold higher intracellular concentration <b>of</b> <b>the</b> <b>drug</b> compared to that obtained when <b>the</b> free <b>drug</b> was administered. Compared to <b>the</b> free <b>drug,</b> <b>the</b> <b>drug</b> conjugate showed significantly higher cytotoxicity towards U 937 cells presumably because of intracellular availability of a pharmacologically active form <b>of</b> <b>the</b> <b>drug.</b> <b>The</b> intracellular product released after lysosomal degradation <b>of</b> <b>the</b> <b>drug</b> conjugate was chromatographically identical to free DXR. These findings merit serious consideration in <b>the</b> development <b>of</b> new chemotherapeutic agents for <b>the</b> treatment <b>of</b> histiocytic malignancies...|$|R
30|$|Outpatient {{prescription}} drug claims {{usually do not}} show <b>the</b> indication <b>of</b> <b>the</b> <b>drug</b> prescribed. Claims for drugs administered by doctors and nurses (e.g., chemotherapy) often show <b>the</b> indication <b>of</b> <b>the</b> <b>drug,</b> but these data are not available for Mexico.|$|R
25|$|Artemisinin and its endoperoxides {{derivatives}} {{have been}} used for the treatment of P. falciparum related infections but low bioavailability, poor pharmacokinetic properties and high cost <b>of</b> <b>the</b> <b>drugs</b> are a major drawback of their use.|$|E
25|$|During its operation, {{treatments}} at Fairfield Hills included hydrotherapy, the use <b>of</b> <b>the</b> <b>drugs</b> metrazol and insulin {{in shock}} therapy, patient seclusion, electroconvulsive therapy, treatment of alcoholism, and frontal lobotomy. In {{the first year}} that psychosurgery was performed at Fairfield Hills over 100 patients were treated.|$|E
25|$|In Koh Chai Cheng's case, {{he denied}} {{knowledge}} <b>of</b> <b>the</b> <b>drugs</b> and contended {{that they had}} been planted in the boot of his car by police informers after he had arrived in Singapore. The trial judges rejected the argument, and the accused was accordingly convicted.|$|E
5000|$|There are {{circumstances}} where the half-life varies with <b>the</b> concentration <b>of</b> <b>the</b> <b>drug.</b> Thus <b>the</b> half-life, under these circumstances, {{is proportional to}} <b>the</b> initial concentration <b>of</b> <b>the</b> <b>drug</b> A0 and inversely proportional to the zero-order rate constant k0 where: ...|$|R
2500|$|... "The quality <b>of</b> <b>the</b> <b>drug</b> must {{correspond}} to <b>the</b> strength <b>of</b> <b>the</b> disease...it {{is best to}} experiment first using the weakest [...] and then increase it gradually until you know <b>the</b> potency <b>of</b> <b>the</b> <b>drug,</b> leaving no room for doubt." ...|$|R
5000|$|Some {{scholars}} have cited the crack [...] "epidemic" [...] {{as an example}} of a moral panic, noting that the explosion in use and trafficking <b>of</b> <b>the</b> <b>drug</b> actually occurred after <b>the</b> media coverage <b>of</b> <b>the</b> <b>drug</b> as an [...] "epidemic." ...|$|R
